Leidos Holdings, US5253271028

Leidos Holdings Stock - BofA Securities downgrades after steep slide

18.06.2026 - 17:16:57 | ad-hoc-news.de

Leidos Holdings stock comes under additional pressure after BofA Securities cuts its rating from Buy to Neutral. The move follows a sharp share-price decline and growing concerns around key government IT contracts.

Leidos Holdings, US5253271028
Leidos Holdings, US5253271028

Edited by ad hoc news Chart & Technicals Desk. Verified prior to publication on 06/18/2026, 17:10 CET. Details in the imprint.

Leidos Holdings (US5253271028) faces fresh scrutiny from Wall Street after a rapid pullback in recent sessions. BofA Securities downgraded the stock from Buy to Neutral on 06/17/2026, citing valuation and contract risk, as reported by Fintel.

Go deeper

All news and analysis on Leidos Holdings stock

Stay on top of rating changes, contract news and price data for Leidos Holdings with our curated topic overview.

BofA Securities turns more cautious

According to a Fintel summary of a BofA Securities note, the broker cut its recommendation on Leidos Holdings from Buy to Neutral on 06/17/2026. The update references the New York Stock Exchange listing under the ticker LDOS.

The same report cites an average one-year price target of $185.31 as of 06/09/2026, with individual estimates ranging from $141.40 to $236.25. That average implies significant upside from a latest closing price reported at $108.67 per share.

Thursday focus - technical picture after the downgrade

Leidos Holdings shares have sold off sharply in recent sessions. GuruFocus notes that on 06/17/2026 the stock fell 4.3% to $108.67, extending a 10.4% drop over one week and a 39.4% decline year-to-date.

That price sits just above the 52-week low of $108.00 and far below the 52-week high of $205.77, underlining how sentiment has weakened. GuruFocus estimates a GF Value of $166.79, around 34.8% above the cited market price.

A separate analysis on Yahoo Finance highlights concerns around the Defense Health Agency's plan to shift away from Leidos as primary integrator for its electronic health record program. This contract risk has weighed on the shares alongside the broader rerating.

Against this backdrop, intraday data from eToro showed Leidos Holdings trading around $123.72 on 06/18/2026, up strongly on the day after recent losses. Short-term volatility remains elevated as investors digest both the downgrade and contract headlines.

How the company makes money

Leidos Holdings generates most of its revenue from technology and engineering services for US government customers, especially in defense, intelligence and civil agencies. Key offerings include systems integration, IT modernization, cyber security and mission support for complex federal programs.

Where the stock trades today

The shares of Leidos Holdings (US5253271028) trade on the New York Stock Exchange under the ticker LDOS at about $123.72 as of 06/18/2026, 16:00 ET, according to composite quote data.

Key facts on Leidos Holdings stock

  • Company: Leidos Holdings, Inc.
  • ISIN: US5253271028
  • Ticker: LDOS
  • Venue: NYSE
  • Price (as of 06/18/2026, 16:00 ET): 123.72 USD
  • Market cap: about 13.7 billion USD (as of 06/17/2026)
  • Sector / Industry: Information Technology / IT Services & Defense Technology
  • Index membership: Standard & Poor's 500 index
  • Next earnings date: not officially scheduled

More on Leidos Holdings stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

en | US5253271028 | LEIDOS HOLDINGS | boerse | 69574076 | bgmi